Skip to main content

Adding Research Publications to What We Know About Advil (Ibuprofen) and COVID-19 – September 23, 2020

Richard Petruschke, PharmD

Your safety, health, and trust in Advil (ibuprofen) is a huge responsibility that we take very seriously at GSK Consumer Healthcare.

We know you’ve had questions about taking ibuprofen to treat COVID-19 symptoms and may have wondered if ibuprofen can make COVID-19 or other respiratory illnesses worse. These questions may arise again as we head into this upcoming flu season and you reach for ibuprofen/Advil to treat flu-associated pain and fever when ill, just like you have in the past.

We’ve been constantly monitoring and evaluating research papers recently published in a broad range of scientific or academic journals around the world. Experts have weighed in, and these papers provide public health authorities and the medical community with an opportunity to review, assess and share knowledge about the safe use of ibuprofen. These experts are from the fields of infectious disease, pain management, respiratory disease, and public health, among other medical fields. 

The scientific consensus is clear. Over-the-counter (OTC) ibuprofen/Advil remains safe to use as directed. The current scientific literature does not show that OTC ibuprofen/Advil makes COVID-19 health outcomes worse, and the world’s leading health authorities have confirmed there is no evidence to recommend that COVID-19 patients avoid OTC ibuprofen. The safety profile of ibuprofen/Advil remains unchanged and information can be reviewed on our site.

We are committed to an ongoing assessment of ibuprofen/Advil. While we have shared information as it became available through this site and other channels, we also want to provide a quick summary here of the research papers that have come to our attention.

Based on the totality of available information, GSK Consumer Healthcare, alongside many public health authorities around the world, is confident in the safe and effective use of OTC Advil when used as directed. Please speak directly with your doctor, pharmacist, or healthcare provider if you have questions about your individual treatment needs.

From everyone at GSK, stay well and be safe.

Recent Research Publications (March to September 2020)

By clicking the link(s) above, you will be taken to an external website that is independently operated and not managed by Haleon. Haleon assumes no responsibility for the content on the website. If you do not wish to leave this website, do not click on the links above.